We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clinigen Group Plc | LSE:CLIN | London | Ordinary Share | GB00B89J2419 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 925.00 | 924.50 | 925.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCLIN
RNS Number : 9757Y
Clinigen Group plc
09 March 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Clinigen Group plc the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------ ------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ü ------------------------------------------------------- ----------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------- ----------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------- ----------------------------- An event changing the breakdown of voting rights ------------------------------------------------------- ----------------------------- Other (please specify): ----------------------------------------------------- ----------------------------- 3. Full name of person(s) Octopus Investments Nominees subject to the Limited notification obligation: (iii) ------------------------------------------------------ ------------------------------ 4. Full name of shareholder(s) n/a (if different from 3.):(iv) ------------------------------------------------------ ------------------------------ 5. Date of the transaction 07/03/2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------ ------------------------------ 6. Date on which issuer 08/03/2017 notified: ------------------------------------------------------ ------------------------------ 7. Threshold(s) that is/are crossed or reached: (vi, vii) 4% ------------------------------------------------------ ------------------------------ 8. Notified details: n/a ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ---------------------------------- ------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ---------------- -------------- ------------------------ ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------ -------------- ---------- ------------ ------------ ----------- GB00B89J2419 4538401 4538401 4605991 4605991 4% ---------------- ---------------- -------------- ---------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- -------------------------------- -------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- -------------- ---------------- -------------------------- ----------------------- Nominal Delta --------------- -------------- -------------- ---------------- -------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------- ----------------------------------------------------------------- 4605991 4% --------------------------------------------------- ----------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------- n/a Proxy Voting: -------------------------------------------------------------------------- 10. Name of the proxy holder: n/a ------------------------------------------------------- ----------------- 11. Number of voting rights proxy n/a holder will cease to hold: ------------------------------------------------------- ----------------- 12. Date on which proxy holder will n/a cease to hold voting rights: ------------------------------------------------------- ----------------- 13. Additional information: ------------------------------------------------------- ----------------- 14. Contact name: Annaliese Maisch ------------------------------------------------------- ----------------- 15. Contact telephone number: 020 7716 6477 ------------------------------------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPDNESSXEEF
(END) Dow Jones Newswires
March 09, 2017 03:58 ET (08:58 GMT)
1 Year Clinigen Chart |
1 Month Clinigen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions